Editorial, J Immunodefic Disor Vol: 1 Issue: 1
Biomarkers in Sepsis and Severe Infection: Where Immunology Meets Diagnostics
Russell J. McCulloh* |
Rhode Island Hospital, Brown University, USA |
Corresponding author : Russell J. McCulloh Rhode Island Hospital,Brown University, USA Tel: 401-444-8365; Fax: 401-444-5650 E-mail:rmcculloh@lifespan.org |
Received: June 30, 2012 Accepted: June 30, 2012 Published: July 03, 2012 doi:10.4172/2324-853X.1000e104 |
Citation: Russell J. McCulloh (2012) Biomarkers in Sepsis and Severe Infection: Where Immunology Meets Diagnostics . J Immunodefic Disor 1:1. doi:10.4172/2324-853X.1000e104 |
Abstract
Biomarkers in Sepsis and Severe Infection: Where Immunology Meets Diagnostics
Our rapidly-increasing understanding of inflammatory and antiinflammatory systems and their interactions in states of disease and health provides researchers and clinicians alike new opportunities to more accurately diagnose, and more specifically treat, diffuse panoply of diseases. One area of great interest for further research is the identification and implementation of diagnostic biomarkers for severe infections and sepsis. In both cases clinicians face the difficulty of defining, in precise terms specific to individual patients, the etiology and severity of illness, relying currently on a combination of non-specific diagnostic testing, physical exam, and clinical history.